Within the N2B/N2BA isoforms of the giant protein titin, a cardiac-specific unique sequence (N2Bus) can be phosphorylated by various protein kinases, including PKA, PKG, ERK2, and CaMKII, which reduces titin-based stiffness. Failing human hearts are hypo-phosphorylated at the N2Bus. Specific phosphatases acting on N2Bus are not known. We carried out a yeast-2-hybrid screen using human N2Bus (“bait”) and a human cardiac cDNA library (“prey”) and found the catalytic domain of protein-phosphatase-5 (PP5c) as a binding partner of N2Bus. The interaction was verified by GST-pulldown assays. PP5 is unique within the family of serine/threonine protein phosphatases because of the presence of tetratricopeptide repeats (TPR) at the molecule's N-terminus. PP5 is well expressed in human and mouse hearts and elevated in failing hearts. PP5 is autoinhibited due to interaction of the TPR domain with the catalytic C-terminus. However, PP5 can be activated by proteolytic cleavage of the TPR region, through binding of the TPR domain by arachidonic acid, or via binding of heat-shock-protein-90 (HSP90). In PP5-overexpressing transgenic (TG) mouse hearts, we found PP5 to co-localize with the titin-N2Bus in the sarcomeric I-band, as shown by immunofluorescence and immunoelectron microscopy. Autoradiography/back-phosphorylation assays and the detection of N2Bus-phosphosites by phospho-specific anti-titin antibodies showed that recombinant PP5 dephosphorylates recombinant human N2Bus previously phosphorylated by ERK2, PKA, or PKG. PP5 also dephosphorylates the cardiac titin isoforms, N2B and N2BA, in human heart tissue. PP5 TG mouse hearts showed reduced N2Bus phosphorylation compared to wildtype (WT) hearts. Force measurements on permeabilized single cardiomyocytes revealed increased passive stiffness in PP5 TG vs. WT hearts. To conclude, PP5 binds to titin N2Bus and acts as an antagonist to the protein-kinase-mediated effects on titin stiffness. Inhibition of the PP5 effect on titin might benefit stiff hearts.
Read full abstract